RADNOSTIX INC — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
On June 25, 2026, Radnostix Inc. (INIS, OTC) closed an asset purchase from Lucerno Dynamics LLC for medical device IP including the Lara System, Lara Sensor Pad, and Ellexa Explorer Software. Initial consideration: $150,000 cash + $750,000 stock (20-day VWAP basis). Contingent payments: $500,000 stock for regulatory milestone (H.R. 2541 passage within 7 years); $250,000 stock for sales milestone (19 unit placements within 7 years); plus earnout payments on product revenue (capped at $40M aggregate). Separately, on June 23, 2026, Radnostix borrowed $500,000 convertible note from Kershner Grosso Co. (Chairman Christopher Grosso's entity) at 5% interest, convertible at $0.07/share, maturing June 30, 2031.
Why this rating
Asset deal is material to $6M company (~15% of market cap in immediate cash/stock). Earnout structure creates upside but is highly contingent on execution and regulatory/sales milestones. Related-party note adds leverage and dilution risk. Moderate business-building transaction but not transformational alone.
Extracted items
- 1.01 material agreement
- 2.01 acquisition/disposition
- 2.03 material obligation
- 3.02
- 9.01 exhibits
View original filing on SEC.gov ↗
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.